Significance of autoimmunity to non-desmoglein targets in pemphigus

References

• Stanley JR, Nishikawa T, Diaz LA, Amagai M. Pemphigus: Is there another half of the story?. J Invest Dermatol 2001; 116(4)489–490
   PubMedGoogle Scholar
• Grando SA, Pittelkow MR, Shultz LD, Dmochowski M, Nguyen VT. Pemphigus: An unfolding story. J Invest Dermatol 2001; 117(4)990–995
   PubMedGoogle Scholar
• Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67(5)869–877
   PubMed Web of Science ®Google Scholar
• Karpati S, Amagai M, Prussick R, Cehrs K, Stanley JR. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol 1993; 122(2)409–415
   PubMed Web of Science ®Google Scholar
• Schmidt E, Brocker EB, Zillikens D. Pemphigus. Loss of desmosomal cell–cell contact. Hautarzt 2000; 51(5)309–318
   PubMedGoogle Scholar
• Hertl M, Veldman C. Pemphigus—paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol Appl Skin Physiol 2001; 14(6)408–418
   PubMedGoogle Scholar
• Amagai M. Desmoglein as a target in autoimmunity and infection. J Am Acad Dermatol 2003; 48(2)244–252
   PubMedGoogle Scholar
• Payne AS, Hanakawa Y, Amagai M, Stanley JR. Desmosomes and disease: Pemphigus and bullous impetigo. Curr Opin Cell Biol 2004; 16(5)536–543
   PubMedGoogle Scholar
• Nguyen VT, Lee TX, Ndoye A, Shultz LD, Pittelkow MR, Dahl MV, Lynch PJ, Grando SA. The pathophysiological significance of non-desmoglein targets of pemphigus autoimmunity: Pemphigus vulgaris and foliaceus patients develop antibodies against keratinocyte cholinergic receptors. Arch Dermatol 1998; 134: 971–980
   PubMedGoogle Scholar
• Kalish RS. Possible role for non-desmoglein antigen in pemphigus. J Invest Dermatol 2001; 117(4)995
   PubMedGoogle Scholar
• Aoyama Y, Owada MK, Kitajima Y. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 1999; 29(7)2233–2240
   PubMedGoogle Scholar
• Delva E, Calkins C, Jennings J, Smith S, Kowalczyk A. Mechanisms of pemphigus vulgaris IgG-induced desmosome disassembly. J Invest Dermatol 2006; 126(4)26, Suppl.
   Google Scholar
• Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 2006; 281(11)7623–7634
   PubMed Web of Science ®Google Scholar
• Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003; 170(4)2170–2178
   PubMed Web of Science ®Google Scholar
• Yeh SW, Cavacini LA, Bhol KC, Lin MS, Kumar M, Duval M, Posner MR, Ahmed AR. Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol 2006; 120(1)68–75
   PubMedGoogle Scholar
• Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994; 94(1)59–67
   PubMedGoogle Scholar
• Memar O, Christensen B, Rajaraman S, Goldblum R, Tyring SK, Brysk MM, McCormick DJ, el-Zaim H, Fan JL, Prabhakar BS. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3). J Immunol 1996; 157(7)3171–3177
   PubMedGoogle Scholar
• Jamora MJ, Jiao D, Bystryn JC. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003; 48(6)976–977
   PubMedGoogle Scholar
• Zagorodniuk I, Weltfriend S, Shtruminger L, Sprecher E, Kogan O, Pollack S, Bergman R. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris. Int J Dermatol 2005; 44(7)541–544
   PubMedGoogle Scholar
• Yoshida K, Takae Y, Saito H, Oka H, Tanikawa A, Amagai M, Nishikawa T. Cutaneous type pemphigus vulgaris: A rare clinical phenotype of pemphigus. J Am Acad Dermatol 2005; 52(5)839–845
   PubMed Web of Science ®Google Scholar
• Grando SA. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 2000; 201(4)290–295
   PubMedGoogle Scholar
• Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000a; 106(12)1467–1479
   PubMed Web of Science ®Google Scholar
• Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 2000b; 157(4)1377–1391
   PubMedGoogle Scholar
• Evangelista F, Dasher DA, Diaz LA, Li N. The prevalence of autoantibodies against E-cadherin in pemphigus. J Invest Dermatol 2006; 126(4)8, Suppl.
   Google Scholar
• Pitoia F, Moncet D, Glorio R, et al. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires) 2005; 65: 307–310
   PubMed Web of Science ®Google Scholar
• Grando SA. Cholinergic control of epidermal cohesion. Exp Dermatol 2006; 15(4)265–282
   PubMedGoogle Scholar
• Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004a; 279(3)2135–2146
   PubMedGoogle Scholar
• Sanchez-Carpintero I, Espana A, Pelacho B, Lopez-Moratalla N, Rubenstein DS, Diaz LA, Lopez-Zabalza MJ. In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol 2004; 151(3)565–570
   PubMedGoogle Scholar
• Kurzen H, Henrich C, Booken D, Poenitz N, Gratchev A, Klemke CD, Engstner M, Goerdt S, Maas-Szabowski N. Functional characterization of the epidermal cholinergic system in vitro. J Invest Dermatol 2006; 29, Jun 29; [Epub ahead of print]
   Google Scholar
• van Koppen CJ, Kaiser B. Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 2003; 98(2)197–220
   PubMed Web of Science ®Google Scholar
• Tobin AB. Phosphorylation of phospholipase C-coupled receptors. Pharmacol Ther 1997; 75(2)135–151
   PubMed Web of Science ®Google Scholar
• Selbie LA, Hill SJ. G protein-coupled-receptor cross-talk: The fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci 1998; 19(3)87–93
   PubMed Web of Science ®Google Scholar
• Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995; 105(3)329–333
   PubMedGoogle Scholar
• Asano S, Seishima M, Kitajima Y. Phosphatidylinositol-specific-phospholipase C cleaves urokinase plasminogen activator receptor from the cell surface and leads to inhibition of pemphigus-IgG-induced acantholysis in DJM-1 cells, a squamous cell carcinoma line. Clin Exp Dermatol 2001; 26(3)289–295
   PubMedGoogle Scholar
• Osada K, Seishima M, Kitajima Y. Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 1997; 108(4)482–487
   PubMedGoogle Scholar
• Seishima M, Iwasaki-Bessho Y, Itoh Y, Nozawa Y, Amagai M, Kitajima Y. Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. Arch Dermatol Res 1999; 291(11)606–613
   PubMedGoogle Scholar
• Frusic-Zlotkin M, Pergamentz R, Michel B, David M, Mimouni D, Bregegere F, Milner Y. The interaction of pemphigus autoimmunoglobulins with epidermal cells: Activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann NY Acad Sci 2005; 1050: 371–719
   PubMed Web of Science ®Google Scholar
• Kurzen H, Berger H, Jäger C, Hartschuh W, Näher H, Gratchev A, Goerdt S, Deichmann M. Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin. J Invest Dermatol 2004; 123(5)937–949
   PubMed Web of Science ®Google Scholar
• Grando SA, Kist DA, Qi M, Dahl MV. Human keratinocytes synthesize, secrete and degrade acetylcholine. J Invest Dermatol 1993; 101: 32–36
   PubMed Web of Science ®Google Scholar
• Grando SA, Horton RM, Pereira EFR, Diethelm-Okita BM, George PM, Albuquerque EX, Conti-Fine BM. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995a; 105: 774–781
   PubMed Web of Science ®Google Scholar
• Grando SA, Zelickson BD, Kist DA, Weinshenker D, Bigliardi PL, Wendelschafer-Crabb G, Kennedy WR, Dahl MV. Keratinocyte muscarinic acetylcholine receptors: Immunolocalization and partial characterization. J Invest Dermatol 1995b; 104: 95–100
   PubMed Web of Science ®Google Scholar
• Grando SA. Biological functions of keratinocyte cholinergic receptors. J Investig Dermatol Symp Proc 1997; 2: 41–48
   PubMedGoogle Scholar
• Ndoye A, Buchli R, Greenberg B, Nguyen VT, Zia S, Rodriguez JG, Webber RJ, Lawry MA, Grando SA. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Dermatol 1998; 111(3)410–416
   PubMedGoogle Scholar
• Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Grando SA. Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 2003; 72: 2081–2085
   PubMedGoogle Scholar
• Grando SA, Dahl MV. Activation of keratinocyte muscarinic acetylcholine receptors reverses pemphigus acantholysis. J Eur Acad Dermatol Venereol 1993; 2: 72–86
   Google Scholar
• Nguyen VT, Ndoye A, Grando SA. Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 2000c; 275(38)29466–29476
   PubMedGoogle Scholar
• Grando SA, Horton RM, Mauro TM, Kist DA, Lee TX, Dahl MV. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996; 107: 412–418
   PubMed Web of Science ®Google Scholar
• Lo Schiavo A, Guerrera V, Cozzani E, Aurilia A, Ruocco E, Pinto F. In vivo enalapril-induced acantholysis. Dermatology 1999; 198(4)391–393
   PubMedGoogle Scholar
• Brenner S, Ruocco V, Bialy-Golan A, Tur E, Flaminio C, Ruocco E, Lombardi ML. Pemphigus and pemphigoid-like effects of nifedipine on in vitro cultured normal human skin explants. Int J Dermatol 1999; 38(1)36–40
   PubMedGoogle Scholar
• Grando SA. New approaches to the treatment of pemphigus. J Investig Dermatol Symp Proc 2004; 9(1)84–91
   PubMedGoogle Scholar
• Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004c; 294(2)534–549
   PubMedGoogle Scholar
• Setoyama M, Choi KC, Hashimoto K, Ishihara M, Predeteanu GS, Dinehart S, Predeteanu C, Hamzavi LH, Etoh H. Desmoplakin I and II in acantholytic dermatoses: Preservation in pemphigus vulgaris and pemphigus erythematosus and dissolution in Hailey–Hailey's disease and Darier's disease. J Dermatol Sci 1991; 2(1)9–17
   PubMedGoogle Scholar
• Hashimoto K, Fujiwara K, Tada J, Harada M, Setoyama M, Eto H. Desmosomal dissolution in Grover's disease, Hailey–Hailey's disease and Darier's disease. J Cutan Pathol 1995; 22(6)488–501
   PubMedGoogle Scholar
• Hakuno M, Shimizu H, Akiyama M, Amagai M, Wahl JK, Wheelock MJ, Nishikawa T. Dissociation of intra- and extracellular domains of desmosomal cadherins and E-cadherin in Hailey–Hailey disease and Darier's disease. Br J Dermatol 2000; 142(4)702–711
   PubMedGoogle Scholar
• Dhitavat J, Cobbold C, Leslie N, Burge S, Hovnanian A. Impaired trafficking of the desmoplakins in cultured Darier's disease keratinocytes. J Invest Dermatol 2003; 121(6)1349–1355
   PubMedGoogle Scholar
• Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005; 115(4)888–899
   PubMed Web of Science ®Google Scholar
• Bystryn JC, Grando SA. A novel explanation for acantholysis in pemphigus vulgaris: The basal cell shrinkage hypothesis. J Am Acad Dermatol 2006; 54(3)513–516
   PubMedGoogle Scholar
• Kim SC, Chung YL, Kim J, Cho NJ, Amagai M. Pemphigus vulgaris with autoantibodies to desmoplakin. Br J Dermatol 2001; 145(5)838–840
   PubMedGoogle Scholar
• Wilgram GF, Caulfield JB, Lever WF. An electron microscopic study of acantholysis in pemphigus vulgaris. J Invest Dermatol 1961; 36: 373–382
   PubMed Web of Science ®Google Scholar
• Kitajima Y, Inoue S, Yaoita H. Effects of pemphigus antibody on the organization of microtubules and keratin-intermediate filaments in cultured human keratinocytes. Br J Dermatol 1986; 114(2)171–179
   PubMedGoogle Scholar
• Barlow Y, Wray D. Ultrastructural alterations associated with in vivo and in vitro bound pemphigus antibodies in cultured oral epithelial cells. J Oral Pathol Med 1991; 20(5)241–244
   PubMedGoogle Scholar
• Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, Nishikawa T. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 2004; 122(5)1145–1153
   PubMedGoogle Scholar
• Nishimura H, Strominger JL. Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases. Proc Natl Acad Sci USA 2006; 103: 3292–3297
   PubMed Web of Science ®Google Scholar
• Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90(3)919–926
   PubMedGoogle Scholar
• Anhalt G, Werth V, Strober B, Connolly M, Korman N, Greenstein D, Fantasia J, Kalish R. An open-label phase I clinical study to assess the safety of PI-0824 in patients with pemphigus vulgaris. J Invest Dermatol 2005; 125: 1088
   Web of Science ®Google Scholar
• Elias P, Ahn S, Brown B, Crumrine D, Feingold KR. Origin of the epidermal calcium gradient: Regulation by barrier status and role of active vs. passive mechanisms. J Invest Dermatol 2002; 119(6)1269–1274
   PubMed Web of Science ®Google Scholar
• Denda M, Tomitaka A, Akamatsu H, Matsunaga K. Altered distribution of calcium in facial epidermis of aged adults. J Invest Dermatol 2003; 121(6)1557
   PubMedGoogle Scholar
• Brenner S, Tur E, Shapiro J, Ruocco V, D'Avino M, Ruocco E, Tsankov N, Vassileva S, Drenovska K, Brezoev P, Barnadas MA, Gonzalez MJ, Anhalt G, Nousari H, Ramos-e-Silva M, Pinto KT, Miranda MF. Pemphigus vulgaris: Environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001; 40(9)562–569
   PubMedGoogle Scholar
• Mehta JN, Martin AG. A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol 2000; 136(1)15–17
   PubMedGoogle Scholar
• Nguyen VT, Arredondo J, Chernyavsky AI, Pittelkow MR, Kitajima Y, Grando SA. Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 2004b; 140(3)327–334
   PubMedGoogle Scholar
• Namazi MR. Practice pearl: Gargling with cholinergic ophthalmic drops for treating the oral lesions of pemphigus vulgaris. J Drugs Dermatol 2004; 3: 484–485
   Google Scholar
• Iraji F, Yoosefi A. Healing effect of Pilocarpine gel 4% on skin lesions of pemphigus vulgaris. Int J Dermatol 2006; 45(6)743–746
   PubMedGoogle Scholar
• Winkelman RK, Sams WM, Jr., Bohr DF. Effect of nicotinate ester, acetylcholine, and other vasodilating agents on cutaneous and mesenteric vascular smooth muscle. Circ Res 1969; 25: 687–692
   PubMedGoogle Scholar
• Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: A review of 13 cases. J Am Acad Dermatol 1993; 28: 998–1000
   PubMed Web of Science ®Google Scholar
• Stoytcheva M, Zlatev R. Bioelectrocatalytical studies of the effect of some pharmaceuticals on the acetylcholinesterase activity. Electroanalysis 1996; 8: 676–679
   Web of Science ®Google Scholar
• Kawashima K, Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 2004; 9: 2063–2085
   PubMed Web of Science ®Google Scholar
• Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004; 9(2)131–143
   PubMedGoogle Scholar
• Arredondo J, Chernyavsky AI, Karaouni A, Grando SA. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus. Am J Pathol 2005; 167(6)1531–1544
   PubMed Web of Science ®Google Scholar
• Liu X, Van Vleet T, Schnellmann RG. The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol 2004; 44: 349–370
   PubMed Web of Science ®Google Scholar
• Weiske J, Schoneberg T, Schroder W, Hatzfeld M, Tauber R, Huber O. The fate of desmosomal proteins in apoptotic cells. J Biol Chem 2001; 41175–41181
   PubMedGoogle Scholar
• Kurzen H. The extraneuronal cholinergic system of the skin: Basic facts and clinical relevance. Hautarzt 2004; 55: 453–459
   PubMedGoogle Scholar
• Brocq L. Les pemphigus. La pratique dermatologique, E Besnier, L Brocq, L Jacquet. Masson, Paris 1902; 721–838
   Google Scholar
• Darier FJ. Precis de dermatologie. Masson et Cie, Paris 1923
   Google Scholar
• Nikolskiy PV. The materials on the study of pemphigus foliaceus cazenavi Thesis [Doctor of Medicine]. The St Vladimir Emperor University of Kiev, Department of Dermatology and Venereology 1896.
   Google Scholar
• Kartamyshev AI. Pemphigus vulgaris. Kiev, USSR 1949
   Google Scholar
• Cremniter D, Baudin M, Roujeau JC, et al. Stressful life events as potential triggers of pemphigus. Arch Dermatol 1998; 134: 1486–1487
   PubMedGoogle Scholar
• Goldberg I, Ingher A, Brenner S. Pemphigus vulgaris triggered by rifampicin and emotional stress. Skinmed 2004; 3: 294
   PubMedGoogle Scholar
• Grando SA, Pittelkow MR, Schallreuter KU. Adrenergic and cholinergic control in the biology of epidermis: Physiological and clinical significance. J Invest Dermatol 2006, (in press)
   PubMedGoogle Scholar